Loading...
The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis
The remarkable clinical efficacy of anti-CD20 monoclonal antibodies (mAb) in relapsing-remitting multiple sclerosis points at the critical involvement of B cells in the disease. However, the exact pathogenic contribution of B cells is poorly understood. In this publication we review new data on the...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3680746/ https://ncbi.nlm.nih.gov/pubmed/23781220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2013.00145 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|